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progressive loss of the articular cartilage matrix due to an imbalance
between matrix synthesis and degradation. Loss in the chondrocytes ability
to respond to growth factor stimulation may be a key factor contributing
to the development of OA and RA. We recently found that enforced expres-
sion of SOCS3 caused IGF-1 resistance in chondrocytes, thereby preventing
upregulation of matrix proteoglycan synthesis. This study is designed to
determine the expression of SOCS3 in human pathological chondrocytes
and unravel the biological/functional consequences.
Methods: Chondrocytes were isolated from cartilage of patients under-
going surgical joint replacement. The mRNA and protein levels of SOCS1
and SOCS3 were measured by qPCR and Western blotting. Levels of
SOCS3 were compared to a human immortalized chondrocyte cell-line
(G6), mesenchymal-stem cells differentiated chondrocytes, and primary
chondrocytes isolated from healthy bovine cartilage or from a SLE patient.
The regulation of SOCS1 and 3 expression was studied in OA chondrocytes
by incubation with different cytokines and TLR agonists. To determine the
functional consequences the cytokine and TLR ligand-induced nitric-oxide
production and IGF-1-stimulated proteoglycan (PG) synthesis was studied.
Results: The SOCS3 mRNA expression in articular chondrocytes and car-
tilage was markedly upregulated (32-fold) in 21/24 OA, 5/5 RA patients,
3/3 trauma patients tested, as compared to the G6 cell-line, stem cell-
differentiated chondrocytes, and chondrocytes derived from a SLE-patient.
Exposure of the mesenchymal stem cell-derived chondrocytes with con-
ditioned media of OA synovial explants upregulated SOCS3 to the same
extent as seen in the OA chondrocytes. Expression of SOCS3 could not
be upregulated signiﬁcantly in OA chondrocytes by the different cytokines
(IL-1β, IL-17, IL-18) and TLR ligands (LPS, Pam2Cys, Poly(I:C), FK156, MDP)
used. In contrast, SOCS1 expression was markedly lower (20-fold) in
comparison to SOCS3 in OA chondrocytes and could be upregulated to the
level of SOCS3 using IL-1β, IFNγ, IL-17, Pam2Cys, Poly(I:C), and especially
with the combination of IFNγ and Poly(I:C). SOCS3 expression in OA
chondrocytes was conﬁrmed at the protein level. This means that at least
in SOCS3 and SOCS1 genes are independently regulated and that SOCS3 has
reached the maximal expression level. In the OA chondrocytes, the TLR4
ligand LPS was unable to induce NO production and IGF-1 failed to stim-
ulate PG synthesis. Forced expression of SOCS3 in bovine cartilage-derived
chondrocytes blocked the LPS (NO) and IGF-1 (PG-synthesis) response in
these cells.
Conclusions: We found increased SOCS3 but not SOSC1 expression in
human pathological chondrocytes. SOCS3 could block TLR4 and IGF-1
activation in chondrocytes. This suggests that SOCS3 modiﬁes normal chon-
drocyte function and this could play a major role in cartilage pathology
during arthritis.
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Purpose: Patient heterogeneity is probably one of the reasons for failure
of osteoarthritis (OA) clinical trials. OA research has focused on cartilage
destruction, while recent evidence shows other joint tissues, including
adipose and synovial tissue, also play important roles in OA pathogenesis.
Current literature indicates overweight is not only mechanically associated
with OA, but also biochemically. Synovium modiﬁcation leading to cartilage
destruction is hypothesized to be a possible mechanism in OA development.
We aim to investigate the inﬂuence of OA-derived synovium, in relation to
body mass index (BMI), on cartilage metabolism.
Methods: Synovium of 16 OA and 8 healthy human donors with different
BMI was cultured alone or together with bovine cartilage explants with
or without stimulation by IL-1α. After 7 days, proteoglycan (PG) release,
matrix metalloproteinase (MMP) activity and cytokines were measured.
Cytokine proﬁles were subjected to multivariate analysis.
Results: Co-cultures of healthy or OA synovium with cartilage showed
no differences in PG release without IL-1α stimulation. However, IL1-α
stimulated co-cultures lead to a higher PG release from cartilage for OA
compared to healthy synovium (54% vs 45% p=0.03). OA donors having
BMI>30 induced a higher PG release then donors having BMI<30 (57% vs
48% p=0.006). With respect to MMP activity, no differences between OA
and healthy synovium were observed. Multivariate analysis showed that
synovium alone or in co-culture with cartilage can be distinguished based
on their cytokine proﬁle.
Conclusions: PG-release, a major process in OA development, is more
prominent in co-cultures with OA-derived synovium compared to healthy
synovium. BMI might prove to be a useful tool to stratify OA patient as
synovium explants of high BMI OA donors lead to more cartilage degrada-
tion then synovium explants of low BMI OA donors. Interaction between
synovium and cartilage leads to modiﬁcation of cytokine proﬁles.
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Purpose: Cartilage and synovial tissue are both affected in osteoarthritis
(OA) and are known to interact. However, a long-term co-culture model
with synovial tissue and cartilage explants has not been described before.
Such a co-culture will provide a suitable model to study these interactions
and mimic the OA joint more closely as well as to screen new therapies for
cartilage degeneration in OA. Therefore, the aim of the study is to develop
an in vitro model that includes both OA synovial tissue and cartilage, which
can be used for testing new therapies for OA.
Methods: Osteoarthritic cartilage and synovial tissue were cultured to-
gether or alone for 21 days. To screen the effect of a therapeutic compound
in the co-culture model, Triamcinolone 0.1mM was added to the culture
media. To assess viability of the synovial tissue immunohistochemistry, a
live/dead assay, and the release of lactate dehydrogenase (LDH) were used.
Dimethylmethylene-blue assay was used to determine glycosaminoglycan
(GAG) release and content of cartilage. Multiplex ELISA was used to deter-
mine the concentrations of secreted IL1, IL1-RA, IL4, IL6, IL7, IL8, IL10, IL13,
TNF-alfa, oncostatin M, IFN-gamma, osteoprotegerin in the culture media.
Results: Throughout the entire culture synovial tissue showed viable cells
by a LDH assay, a live/dead assay and immunohistochemistry demonstrated
the presence of macrophages and T-cells. Several cytokines, which were
previously demonstrated in synovial ﬂuid of osteoarthritic patients, were
secreted by synovial tissue during the entire culture period, indicating that
the synovial tissue is still capable of producing cytokines during culture.
Co-culture of cartilage and synovial tissue enhanced GAG release and
reduced GAG content after 21 days of culture compared to cartilage
Figure 1. GAG content from 6 donors (mean ± SD in μg GAG/gram cartilage; *P<0.05).
Figure 2. GAG content co-culture cultured with or without Triamcinolone (mean ± SD in
μg GAG/gram cartilage).
